These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27587370)

  • 61. Optimizing the combination insulin bolus split for a high-fat, high-protein meal in children and adolescents using insulin pump therapy.
    Lopez PE; Smart CE; McElduff P; Foskett DC; Price DA; Paterson MA; King BR
    Diabet Med; 2017 Oct; 34(10):1380-1384. PubMed ID: 28574182
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of carbohydrate counting using bolus calculators on glycemic control in type 1 diabetes patients during continuous subcutaneous insulin infusion.
    Yamada E; Okada S; Nakajima Y; Bastie CC; Tagaya Y; Osaki A; Shimoda Y; Shibusawa R; Saito T; Ozawa A; Yamada M
    J Diabetes Investig; 2017 Jul; 8(4):496-500. PubMed ID: 27896954
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial.
    Ziegler R; Cavan DA; Cranston I; Barnard K; Ryder J; Vogel C; Parkin CG; Koehler W; Vesper I; Petersen B; Schweitzer MA; Wagner RS
    Diabetes Care; 2013 Nov; 36(11):3613-9. PubMed ID: 23900590
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A Simplified Semiquantitative Meal Bolus Strategy Combined with Single- and Dual-Hormone Closed-Loop Delivery in Patients with Type 1 Diabetes: A Pilot Study.
    Gingras V; Haidar A; Messier V; Legault L; Ladouceur M; Rabasa-Lhoret R
    Diabetes Technol Ther; 2016 Aug; 18(8):464-71. PubMed ID: 27191385
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pump It Up! A randomized clinical trial to optimize insulin pump self-management behaviors in adolescents with type 1 diabetes.
    O'Donnell HK; Vigers T; Johnson SB; Pyle L; Wright N; Deeb LC; Driscoll KA
    Contemp Clin Trials; 2021 Mar; 102():106279. PubMed ID: 33440262
    [TBL] [Abstract][Full Text] [Related]  

  • 66. DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home.
    Biester T; Nir J; Remus K; Farfel A; Muller I; Biester S; Atlas E; Dovc K; Bratina N; Kordonouri O; Battelino T; Philip M; Danne T; Nimri R
    Diabetes Obes Metab; 2019 Apr; 21(4):822-828. PubMed ID: 30478937
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Glucose Control Using a Standard Versus an Enhanced Hybrid Closed Loop System: A Randomized Crossover Study.
    Paldus B; Lee MH; Jones HM; McAuley SA; Horsburgh JC; Roem KL; Ward GM; MacIsaac RJ; Cohen N; Colman PG; Jenkins AJ; O'Neal DN
    Diabetes Technol Ther; 2019 Jan; 21(1):56-58. PubMed ID: 30620641
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of treatment with continuous subcutaneous insulin infusion versus multiple daily insulin injections with bolus calculator in patients with type 1 diabetes.
    Pérez-García L; Goñi-Iriarte MJ; García-Mouriz M
    Endocrinol Nutr; 2015; 62(7):331-7. PubMed ID: 26234808
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Minimizing postprandial hypoglycemia in Type 1 diabetes patients using multiple insulin injections and capillary blood glucose self-monitoring with machine learning techniques.
    Oviedo S; Contreras I; Bertachi A; Quirós C; Giménez M; Conget I; Vehi J
    Comput Methods Programs Biomed; 2019 Sep; 178():175-180. PubMed ID: 31416546
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Impact of Sensor-Augmented Pump Therapy with Predictive Low-Glucose Suspend Function on Glycemic Control and Patient Satisfaction in Adults and Children with Type 1 Diabetes.
    Beato-Víbora PI; Quirós-López C; Lázaro-Martín L; Martín-Frías M; Barrio-Castellanos R; Gil-Poch E; Arroyo-Díez FJ; Giménez-Álvarez M
    Diabetes Technol Ther; 2018 Nov; 20(11):738-743. PubMed ID: 30256132
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Efficacy of Basal Rate and Carbohydrate Ratio Learning Algorithm for Closed-Loop Insulin Delivery (Artificial Pancreas) in Youth with Type 1 Diabetes in a Diabetes Camp.
    Palisaitis E; El Fathi A; Von Oettingen JE; Krishnamoorthy P; Kearney R; Jacobs P; Rutkowski J; Legault L; Haidar A
    Diabetes Technol Ther; 2020 Mar; 22(3):185-194. PubMed ID: 31596127
    [No Abstract]   [Full Text] [Related]  

  • 72. Sleep and diabetes-specific psycho-behavioral outcomes of a new automated insulin delivery system in young children with type 1 diabetes and their parents.
    Bisio A; Brown SA; McFadden R; Pajewski M; Yu PL; DeBoer M; Schoelwer MJ; Bonner HG; Wakeman CA; Cherñavvsky DR; Gonder-Frederick L
    Pediatr Diabetes; 2021 May; 22(3):495-502. PubMed ID: 33289242
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Insulin Therapy and Diabetic Pregnancy.
    Napoli A
    Am J Ther; 2020; 27(1):e91-e105. PubMed ID: 31688066
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Benefits of a bolus calculator in pre- and postprandial glycaemic control and meal flexibility of paediatric patients using continuous subcutaneous insulin infusion (CSII).
    Shashaj B; Busetto E; Sulli N
    Diabet Med; 2008 Sep; 25(9):1036-42. PubMed ID: 18937673
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Development of a New Measure for Assessing Insulin Delivery Device Satisfaction in Patients with Type 1 and Type 2 Diabetes.
    Polonsky WH; Fisher L; Hessler D; Edelman SV
    Diabetes Technol Ther; 2015 Nov; 17(11):773-9. PubMed ID: 26167948
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.
    El-Khatib FH; Balliro C; Hillard MA; Magyar KL; Ekhlaspour L; Sinha M; Mondesir D; Esmaeili A; Hartigan C; Thompson MJ; Malkani S; Lock JP; Harlan DM; Clinton P; Frank E; Wilson DM; DeSalvo D; Norlander L; Ly T; Buckingham BA; Diner J; Dezube M; Young LA; Goley A; Kirkman MS; Buse JB; Zheng H; Selagamsetty RR; Damiano ER; Russell SJ
    Lancet; 2017 Jan; 389(10067):369-380. PubMed ID: 28007348
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial.
    Wan W; Skandari MR; Minc A; Nathan AG; Zarei P; Winn AN; O'Grady M; Huang ES
    Med Decis Making; 2018 Nov; 38(8):942-953. PubMed ID: 30403576
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Bolus calculator improves long-term metabolic control and reduces glucose variability in pump-treated patients with Type 1 diabetes.
    Lepore G; Dodesini AR; Nosari I; Scaranna C; Corsi A; Trevisan R
    Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):e15-6. PubMed ID: 22673770
    [No Abstract]   [Full Text] [Related]  

  • 79. Insulin Management for Type 1 Diabetic Patients During Social Alcohol Consumption: The SPRITZ Study.
    Cipponeri E; Blini C; Lamera C; De Mori V; Veronesi G; Bossi AC
    Curr Diabetes Rev; 2020; 16(6):619-627. PubMed ID: 32552634
    [TBL] [Abstract][Full Text] [Related]  

  • 80. White Coat Adherence in Pediatric Patients With Type 1 Diabetes Who Use Insulin Pumps.
    Driscoll KA; Wang Y; Bennett Johnson S; Lynch R; Stephens H; Willbur K; Gill E; Wright N; Deeb LC
    J Diabetes Sci Technol; 2016 May; 10(3):724-9. PubMed ID: 26746686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.